Generic Name : Idarubicin Pronunciation : eye-duh-ROO-bih-sin
Therapeutic Classification : Chemotherapy Trade Name(s):
International- Idamycin. Why it is prescribed (Indications) : This medication is an anthracycline antileukemia agent, prescribed for acute myeloid leukemia (AML). It inhibits activities of cancer cells. When it is not to be taken (Contraindications): Hypersensitivity.
Dosage & When it is to be taken : IV- The recommended dose is 12 mg/m² daily for 3 days by slow (10 to 15 min) infusion in combination with cytarabine. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into the vein. Warnings and Precautions :
* Caution should be exercised in patients with history of anemia, heart, liver, or kidney problems; bone marrow depression, infection, poor immunity, any allergy, who are taking this medications, children, elderly, during pregnancy and breastfeeding.
* It may reduce platelet counts; avoid injury or bruising.
* Avoid contact with people who have infections.
* Avoid live vaccination during treatment period. Side Effects :
Most Common - Infection, nausea, vomiting, hair loss, abdominal cramps, diarrhea, mental illness, fever, headache, nerve disease, lung allergy and seizures.
Heart - Heart failure, chest pain and heart attack.
Skin - Hair loss, rash, hives and redness.
* Avoid excess dosage. Storage Conditions :
Store it at controlled room temperature (15 to 30°C).
Comment & Contribute
Ask an Expert